Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Syncillin in bacterial skin diseases]

H J Suschke

    Fortschritte Der Medizin
    |June 3, 1976
    PubMed
    Summary
    This summary is machine-generated.

    This clinical trial found Syncillin (Azidocillin) effective for bacterial skin diseases, with 74% of patients cured. The antibiotic showed good tolerance, with common side effects like nausea and diarrhea not requiring treatment discontinuation.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Diagnosis of paediatric Lyme arthritis using a clinical score.

    European journal of pediatrics·1998
    Same author

    Immunogenetics of juvenile chronic arthritis. I. HLA interaction between A2, DR5/8-DR/DQ, and DPB1*0201 is a general feature of all subsets of early onset pauciarticular juvenile chronic arthritis II. DPB1 polymorphism plays a role in systemic juvenile chronic arthritis.

    Tissue antigens·1995
    Same author

    Lyme arthritis in European children and adolescents. The Pediatric Rheumatology Collaborative Group.

    Arthritis and rheumatism·1995
    Same author

    [Treatment of juvenile spondylarthritis and reactive arthritis with sulfasalazine].

    Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde·1992
    Same author

    [Fatal course of juvenile chronic arthritis].

    Klinische Padiatrie·1990
    Same author

    [Therapy of juvenile chronic arthritis with sulfasalazine].

    Zeitschrift fur Rheumatologie·1987
    Same journal

    [More information--less pain. Procedure in pain following amputation of limbs. Brachial plexus injury and nerve root avulsion. Interview by Susanne Kammerer].

    Fortschritte der Medizin·1999
    Same journal

    [Galenic alternatives to unstable tocopherol acetate. "Smeared" or cheated?--Vitamin E in facial ointments].

    Fortschritte der Medizin·1999
    Same journal

    [Gene diagnosis in the hand of the physician].

    Fortschritte der Medizin·1999
    Same journal

    [Is non-toxic cancer therapy through biotechnology a possibility?].

    Fortschritte der Medizin·1999
    Same journal

    [Smoking withdrawal in practice and clinic].

    Fortschritte der Medizin·1999
    Same journal

    [The future of pancreas diagnosis. An exclusive training service of the Gastro-Ligue for dermatologists].

    Fortschritte der Medizin·1999
    See all related articles

    Area of Science:

    • Dermatology
    • Pediatrics
    • Infectious Diseases

    Context:

    • Bacterial skin infections require effective systemic therapy.
    • Evaluating new antibiotic treatments is crucial for managing dermatological conditions.

    Purpose:

    • To assess the efficacy and safety of Syncillin (Azidocillin) in treating bacterial skin diseases.
    • To analyze bacteriological outcomes and clinical improvement in patients receiving Syncillin.

    Summary:

    • A multicentric open trial involved 96 patients with bacterial skin diseases treated with Syncillin (Azidocillin) for 10 days.
    • 74% of patients were cured, 22% improved, and 4% showed no change. Bacterial persistence in 10 cases did not prevent positive clinical outcomes.
    • The drug was well-tolerated, with mild side effects like nausea and diarrhea reported in some patients, but none necessitated treatment cessation.

    Related Experiment Videos

    Impact:

    • Syncillin (Azidocillin) offers a viable therapeutic option for bacterial skin infections.
    • The study supports the use of rational chemotherapy in treating skin diseases.
    • Findings contribute to understanding antibiotic efficacy in pediatric and adult dermatology.